2142 Combined weekly taxol and radiotherapy of stage III inoperable non small cell lung cancer (NSCLC)-results of a dose escalation study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(97)80909-1 ◽

1997 ◽

Vol 39 (2) ◽

pp. 311

Author(s):

J. Willner ◽

M. Flentje ◽

M. Schmidt ◽

H. Wirtz ◽

R.M. Huber ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Stage Iii ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

Dose-Escalation Study of Three-Dimensional Conformal Thoracic Radiotherapy With Concurrent S-1 and Cisplatin for Inoperable Stage III Non–Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2013.01.003 ◽

2013 ◽

Vol 14 (4) ◽

pp. 440-445 ◽

Author(s):

Hideyuki Harada ◽

Makoto Nishio ◽

Haruyasu Murakami ◽

Fumiyoshi Ohyanagi ◽

Takuyo Kozuka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Three Dimensional ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

A phase I dose escalation study of cisplatin, pemetrexed and radiotherapy for inoperable stage III non-small cell lung cancer

http://isrctn.org/> ◽

10.1186/isrctn91946477 ◽

2013 ◽

Author(s):

V F M Surmont

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Stage Iii ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6600464 ◽

2002 ◽

Vol 87 (3) ◽

pp. 258-263 ◽

Author(s):

M Yamada ◽

S Kudoh ◽

H Fukuda ◽

K Nakagawa ◽

N Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Unresectable Stage

Download Full-text

Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)01361-0 ◽

2003 ◽

Vol 57 (2) ◽

pp. S417-S418 ◽

Author(s):

K.E Rosenzweig ◽

E Yorke ◽

A Jackson ◽

R Nayak ◽

V.W Rusch ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non–small-cell lung cancer

Journal of Radiation Research ◽

10.1093/jrr/rry058 ◽

2018 ◽

Vol 60 (2) ◽

pp. 228-233

Author(s):

Kyoichi Kaira ◽

Akihiro Ono ◽

Yosuke Kamide ◽

Noriaki Sunaga ◽

Yasuhiko Koga ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Thoracic Radiation

Download Full-text

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-2014 ◽

2018 ◽

Vol 25 (2) ◽

pp. 496-505 ◽

Author(s):

Florence Atrafi ◽

Harry J.M. Groen ◽

Lauren A. Byers ◽

Elena Garralda ◽

Martijn P. Lolkema ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Solid Tumors ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Extensive Stage

Download Full-text

Raltitrexed (‘Tomudex’) and cisplatin in metastatic non-small cell lung cancer (NSCLC): Preliminary results of a Phase I dose-escalation study

European Journal of Cancer ◽

10.1016/s0959-8049(99)81422-1 ◽

1999 ◽

Vol 35 ◽

pp. S253 ◽

Author(s):

C. Manegold ◽

E. Buchholz ◽

R. Kloeppel ◽

C. Kreisel ◽

M. Smith

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Preliminary Results

Download Full-text

Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial?: A Multi-institutional Propensity-Score Matched Analysis

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.05.1933 ◽

2014 ◽

Vol 90 (1) ◽

pp. S654 ◽

Author(s):

G. Rodrigues ◽

S. Senan ◽

C. Oberije ◽

K. Tsujino ◽

T. Wiersma ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Dose ◽

Propensity Score ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Concurrent Chemotherapy ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

Dose Escalation after RTOG 0617: Recent Trends and Predictors of Radiation Doses >70 Gy in Stage III Non-Small Cell Lung Cancer from the National Cancer Database

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.1291 ◽

2020 ◽

Vol 108 (3) ◽

pp. e137

Author(s):

D.M. Harris ◽

M. Soike ◽

A.M. Hegde ◽

H. Boggs ◽

M. Bredel ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Stage Iii ◽

Radiation Doses ◽

National Cancer Database ◽

Small Cell Lung ◽

Download Full-text

A dose-escalation study of vorinostat in combination with radiotherapy for patients with non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps286 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS286-TPS286

Author(s):

R. H. Decker ◽

S. N. Gettinger ◽

L. D. Wilson

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text